108 related articles for article (PubMed ID: 9495515)
1. Acute changes in trabecular bone connectivity and osteoclast activity in the ovariectomized rat in vivo.
Lane NE; Thompson JM; Haupt D; Kimmel DB; Modin G; Kinney JH
J Bone Miner Res; 1998 Feb; 13(2):229-36. PubMed ID: 9495515
[TBL] [Abstract][Full Text] [Related]
2. Basic fibroblast growth factor forms new trabeculae that physically connect with pre-existing trabeculae, and this new bone is maintained with an anti-resorptive agent and enhanced with an anabolic agent in an osteopenic rat model.
Lane NE; Kumer J; Yao W; Breunig T; Wronski T; Modin G; Kinney JH
Osteoporos Int; 2003 Jun; 14(5):374-82. PubMed ID: 12768279
[TBL] [Abstract][Full Text] [Related]
3. Early estrogen replacement therapy reverses the rapid loss of trabecular bone volume and prevents further deterioration of connectivity in the rat.
Lane NE; Haupt D; Kimmel DB; Modin G; Kinney JH
J Bone Miner Res; 1999 Feb; 14(2):206-14. PubMed ID: 9933474
[TBL] [Abstract][Full Text] [Related]
4. Clodronate prevents osteopenia and loss of trabecular connectivity in estrogen-deficient rats.
Kippo K; Hannuniemi R; Isaksson P; Laurén L; Osterman T; Peng Z; Tuukkanen J; Kuurtamo P; Väänänen HK; Sellman R
J Bone Miner Res; 1998 Feb; 13(2):287-96. PubMed ID: 9495523
[TBL] [Abstract][Full Text] [Related]
5. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
Lane NE; Yao W; Kinney JH; Modin G; Balooch M; Wronski TJ
J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
[TBL] [Abstract][Full Text] [Related]
6. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
7. Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats.
Turner RT; Wakley GK; Hannon KS; Bell NH
Endocrinology; 1988 Mar; 122(3):1146-50. PubMed ID: 3342747
[TBL] [Abstract][Full Text] [Related]
8. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
Lane NE; Thompson JM; Strewler GJ; Kinney JH
J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
[TBL] [Abstract][Full Text] [Related]
9. Calorie restriction aggravated cortical and trabecular bone architecture in ovariectomy-induced estrogen-deficient rats.
Ahn H; Seo DH; Kim HS; Choue R
Nutr Res; 2014 Aug; 34(8):707-13. PubMed ID: 25172380
[TBL] [Abstract][Full Text] [Related]
10. The beneficial effect of icaritin on osteoporotic bone is dependent on the treatment initiation timing in adult ovariectomized rats.
Peng S; Zhang G; Zhang BT; Guo B; He Y; Bakker AJ; Pan X; Zhen W; Hung L; Qin L; Leung WN
Bone; 2013 Jul; 55(1):230-40. PubMed ID: 23486180
[TBL] [Abstract][Full Text] [Related]
11. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
Ke HZ; Simmons HA; Pirie CM; Crawford DT; Thompson DD
Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
[TBL] [Abstract][Full Text] [Related]
12. Short-term prophylaxis against estrogen depletion-induced bone loss with calcitriol does not provide long-term beneficial effects on cancellous bone mass or structure in ovariectomized rats.
Erben RG; Bromm S; Stangassinger M
Osteoporos Int; 1998; 8(1):82-91. PubMed ID: 9692082
[TBL] [Abstract][Full Text] [Related]
13. Prolonged treatments with antiresorptive agents and PTH have different effects on bone strength and the degree of mineralization in old estrogen-deficient osteoporotic rats.
Cheng Z; Yao W; Zimmermann EA; Busse C; Ritchie RO; Lane NE
J Bone Miner Res; 2009 Feb; 24(2):209-20. PubMed ID: 18847326
[TBL] [Abstract][Full Text] [Related]
14. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
Marie PJ; Hott M; Modrowski D; De Pollak C; Guillemain J; Deloffre P; Tsouderos Y
J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
[TBL] [Abstract][Full Text] [Related]
15. A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats.
Armamento-Villareal R; Sheikh S; Nawaz A; Napoli N; Mueller C; Halstead LR; Brodt MD; Silva MJ; Galbiati E; Caruso PL; Civelli M; Civitelli R
J Bone Miner Res; 2005 Dec; 20(12):2178-88. PubMed ID: 16294271
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of skeletal response to estrogen depletion at red and yellow marrow sites in rats.
Li M; Shen Y; Qi H; Wronski TJ
Anat Rec; 1996 Jul; 245(3):472-80. PubMed ID: 8800405
[TBL] [Abstract][Full Text] [Related]
17. Cancellous bone resorption in the proximal ilium of the ovariectomized rat.
Devlin H; Ferguson MW; Carter DH
Calcif Tissue Int; 1990 Jun; 46(6):395-400. PubMed ID: 2364327
[TBL] [Abstract][Full Text] [Related]
18. Discordance between bone turnover and bone loss: effects of aging and ovariectomy in the rat.
Baldock PA; Need AG; Moore RJ; Durbridge TC; Morris HA
J Bone Miner Res; 1999 Aug; 14(8):1442-8. PubMed ID: 10457278
[TBL] [Abstract][Full Text] [Related]
19. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats.
Wronski TJ; Cintrón M; Dann LM
Calcif Tissue Int; 1988 Sep; 43(3):179-83. PubMed ID: 3141020
[TBL] [Abstract][Full Text] [Related]
20. The effects of raloxifene on tibia histomorphometry in ovariectomized rats.
Evans G; Bryant HU; Magee D; Sato M; Turner RT
Endocrinology; 1994 May; 134(5):2283-8. PubMed ID: 8156931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
